RFK Jr. is waging a war against ultra-processed foods. What does it mean for your diet?
But what is ultra-processed food? There still isn't a universal definition.
While many ice creams, chips and sodas are considered ultra-processed, there's also a wide array of other foods that can be included in a healthy diet that fall into the same category, such as tofu, some canned fruits and vegetables, protein bars, cereals and nut milks.
'These are all quite processed and some of them can be classified as ultra-processed foods but because of their nutrient profiles, they might be better for us and not associated with the worst health outcomes,' said Michele Polacsek, professor of public health at the University of New England and an expert on promoting healthy food choices.
Does that mean these foods will be targeted, too? Probably not, said Marion Nestle, a nutrition expert and emeritus professor at New York University.
'That would be impossible because of the way that Americans eat,' she said, as research shows over 70% of American calories come from ultra-processed foods.
Ultra-processed foods, or UPFs, are foods that have been made by food companies using manufactured ingredients, rather than actual foods. If you've ever taken a look at some food labels, you may not recognize many of the ingredients listed. These are likely ultra-processed ingredients that are used to make food "taste better, look better and last longer on the shelf," Nestle said.
Research has shown UPFs replace healthier foods and encourage people to eat more calories, Nestle said. Ultra-processed foods have been linked to about 30 health conditions, including obesity, diabetes, heart disease, certain cancers and mental health disorders, according to a 2024 study published in the British Medical Journal.
In May, Kennedy and his 'Make America Healthy Again' commission targeted ultra-processed foods in a 69-page report.
The U.S. Department of Health and Human Services announced the administration is seeking information and data to help develop an official definition for ultra-processed foods, according to a July 23 statement.
While it's a good first step, Polacsek said not all UPFs are the same and there isn't enough data to determine which ingredients or processes in packaged foods lead to negative health outcomes.
'We don't have all the evidence we need,' she said. 'We need a lot more research on this.'
It would be a mistake to create policy based on the data available on ultra-processed foods, Polacsek said. But if the administration makes policy decisions based on a universal definition, she hopes agencies will also allocate funding to research how it's impacting public health and the food industry.
Is Chick-fil-A healthy? Fast-food chain named one of the least nutritious in America
In the meantime, Nestle recommends minimizing the amount of ultra-processed foods you eat but also reminds consumers that some contain nutrients that can be incorporated into a healthy diet.
In a 2023 study, researchers at the U.S. Department of Agriculture led a study that showed how it was possible to build a healthy diet with 91% of the calories coming from ultra-processed foods. However, study authors noted the diet was particularly high in sodium and didn't contain enough whole grains.
'The basic principle of healthy eating is variety,' Nestle said. 'If you eat a lot of different kinds of food, and most of them are minimally processed, you're doing fine.'
'Food is one of life's greatest pleasures, it's really important to enjoy what you eat.'
Adrianna Rodriguez can be reached at adrodriguez@usatoday.com.
This article originally appeared on USA TODAY: RFK Jr. and ultra-processed foods: What about protein bars?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Personal space? Not in this household—how one mom learned to embrace her toddler's love (and elbows)
In a now-viral TikTok that's racked up over 1.4 million views, mom @abigail_stacey22 captures a scene many parents know all too well: she's sitting on a large, empty couch—except her toddler is fully on top of her. The video's caption? 'Personal space…I don't know her ' And judging by the comment section, she's far from alone. 'Every single time we should have been born with pouches like kangaroos,' @starks joked. Another mom, @michelle | wfh boy mama added, 'I swear if they could climb back into our bellies they would .' And @Veronica offered the theory many parents have quietly suspected: 'I really think they miss being inside of us. Like there's that little feeling in them that wants to go back.' These replies speak to something both hilariously universal and deeply emotional: the closeness toddlers crave—and the overwhelm parents often feel in response. Related: True life: Toddlers and 'personal space' don't mix When 'touched out' becomes the norm For toddlers, physical proximity is how they feel safe. According to experts, children often seek constant physical contact as a way to regulate emotions, feel protected, and explore their independence from a secure base. For parents, though, especially those juggling work, household responsibilities, and caregiving, that closeness can sometimes feel suffocating. The term 'touched out' describes the sensory overload that can happen when you've had too much physical contact, and it's a very real part of the parenting experience. Needing a break often means your nervous system is overloaded, not that anything is wrong with the bond you share. That's especially true in early motherhood, when someone is quite literally on you for most of the day (and night). Related: I miss having personal space Finding small resets when you're overwhelmed If you're feeling physically and emotionally drained by the closeness, you're not alone—and you're not a bad parent for needing space. A few ways to reset: Name what's happening. Saying out loud, 'I'm feeling touched out right now' can help normalize the experience for yourself and your family. Take micro-breaks. Even stepping outside for 2–3 minutes of fresh air can be enough to shift your energy. Use transition objects. Offer a special pillow or stuffed animal your toddler can cuddle with next to you, instead of always being on you. Involve your partner or support network. Ask for 20 minutes alone in the bedroom or bathroom while someone else holds down the fort. Breathe into the moment. Sometimes, just recognizing this closeness as temporary can soften the edges of the frustration. This is the phase that fills your heart—and your lap Toddlers have no concept of boundaries—and yet, as many seasoned parents will tell you, they soon learn. And when they do, it can be startling how quickly the clinginess gives way to independence. The same couch that once felt crowded with toddler limbs will one day be too empty. That's why videos like @abigail_stacey22's hit so hard. They show the beauty in the mess. The absurdity of having a perfectly good sofa, but becoming the designated seat anyway. And the unspoken truth that many of us are quietly holding onto: these overwhelming moments are also the ones we'll miss the most. So yes—personal space might be a distant memory right now. But in this season of elbows, clingy hugs, and sticky fingers, there's also unmatched closeness. And a love that can't help but sit right on top of you. Solve the daily Crossword
Yahoo
27 minutes ago
- Yahoo
Vystar Introduces New RxAir-800 Replacement Cartridge Extended Life UV-C Bulb
New RxAir400 Pro UV-C bulb replacement cartridge provides 18,000 vs 9,000 hr. use. Worcester, MA, July 30, 2025 (GLOBE NEWSWIRE) -- With heightened concern about protection from harmful airborne viruses, Vystar Corporation's (OTCQB: VYST) RxAir®400 Germicidal Ultraviolet (UV-C) light air purification systems offers new features and options that will make it easier to treat airborne pathogens wherever you go indoors. RxAir400 is a smaller, consumer/small business-sized version of the industrial size Rx3000 FDA-certified Class II medical device UV light air purifier designed for disinfection use in hospitals. RxAir400 will now feature an ergonomic integrated handle for easier room-to-room portability, plus offer two new accessory options: - UV bulbs have limited life for germicidal effectiveness. RxAir units and bulb cartridges have interactive chips that communicate to alert users as the bulb approaches the end of life and needs to be replaced. RxAir 400 comes with its standard 9000 hr. UVC bulb cartridge good for approximately one year of regular use before requiring replacement. The new UVC Pro replacement cartridge has a lifespan of 18,000 hours, or approximately two years of normal use. Cartridges include free return and disposal of spent cartridges. – New low profile wall mount bracket makes it easier to put RxAir in an optimal location when traffic patterns and furniture layout are not conducive to floor placement. The low-profile bracket allows you to easily lift unit off the bracket to transport room to room to safely inactivate >99.9% of pathogens, reducing virus exposure risk in occupied facilities such as schools, restaurants, retail and offices. Vystar's new 18,000 hour cartridge is expected to be in stock in mid- to late Septmeber – just in time as students head back to school. 'A main advantage of RxAir is that it can operate safely in occupied spaces to continuously process the air up to eight times per hour, inactivating or killing the pathogens expelled as people talk, breathe, cough, sneeze or sing to help reduce risk of exposure for those in the room,' stated Bryan Stone, MD, Internal Medicine and Nephrology. 'When near people who aren't wearing masks and may be asymptomatic, it is reassuring to have RxAir treating pathogens they may be expelling.' 'Given the growing body of evidence that Coronavirus SARS CoV-2 may be transmitted through airborne means or aerosolization noted by the CDC1,2, and hundreds of scientists worldwide3,4,5, it is wise to address all modes of possible transmission,' Dr. Stone noted. 'We strongly encourage people to wear face masks and follow other CDC recommended surface and personal disinfection practices, along with using RxAir to decrease their pathogen exposure risk as much as possible.' 'RxAir400's ViraTech technology is one of the few UV light air purification technologies proven in EPA- and FDA-certified laboratory testing to inactivate more than 99.9% of airborne viruses (including multiple coronavirus strains), bacteria and other pathogens that cause pneumonia, influenza, MRSA (staph), streptococcus (strep throat), whooping cough, tuberculosis (TB), common cold, measles and a myriad of other antibiotic-resistant and viral infections,' Dr. Stone explained. 'Hospitals and healthcare facilities have been using ultraviolet germicidal irradiation (UVGI) with UV-C light for airborne infection control for decades because it is so effective. It also reduces concentration of volatile organic compounds and odors as well as air pollution linked to sleep disorders.' Air Purifier Demand Projected to Skyrocket Grandview Research's report in July 2020 stated, 'The enforcement of lockdown across the countries globally has led to the increased demand for air purifiers in the past couple of months. Moreover, as air purifiers are effective against various viruses, the demand in several countries is expected to witness significant growth owing to the outbreak of COVID-19. Few manufacturers are claiming that their air purifiers are an ideal option for neutralizing as well as effectively controlling the spread of coronavirus. In addition, consumers are buying air purifiers across the globe as a precautionary measure to mitigate indoor air pollution and to clean indoor air to avoid the novel coronavirus infection.' Grandview estimated that the global air purifier market size was USD $8.04 billion in 2019 and is expected to register a CAGR of 10.8% through 2027. Market Research firm Arizton Advisory & Intelligence is even more optimistic and is projecting that the global portable air purifier market will grow at a CAGR of around 42% between 2019-2025 to reach $90 billion by 2025 due to 'exponential rise in demand for clean air, owing to the rising population levels coupled with growing respiratory issue and epidemic spread across the globe' Jamie Rotman CEO of Vystar stated, 'with 25,000 RXAIR units operating worldwide the demand for replacement cartridges has grown significantly. Residential users will change the cartridge annually, while commercial customers run the machines longer and require a cartridge change every six months providing a total market of 40,000 cartridge changes per year. The new extended life cartridge can cut that number in half, making production and sales more efficient for Vystar and the customer.' The original cartridge will continue to be priced at $199 while the longer life cartridge will have some cost savings at $375. Vystar is only selling these cartridges directly or through a few select distributors like McKesson Medical-Surgical.' Follow us on social media:Twitter: @VystarCompany @vytexContacts:VystarMedia & Investors: Jamie Rotman, jrotman@ Opportunities: info@ Investors or To Partner with Vystar, Company Phone Number: (508) 791-9114 or contact info@ or 508-791-9114 # # # Sources: 1 Centers for Disease Control (2020, April 29) Decontamination & Reuse of Filtering Facepiece Respirators. (Accessed July 21, 2020)2 Guo Z, Wang Z, Zhang S, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerging Infectious Diseases. 2020;26(7):1583-1591. doi:10.3201/eid2607.200885. (accessed July 14, 2020)3 Coffey, Donavyn, Does UV light kill the new coronavirus?, (July 12, 2020)Live Science, (Accessed July 14, 2020)4 Morawska, L. & Milton, D. It is Time to Address Airborne Transmission of COVID-19, Clinical Infectious Diseases, (2020) (accessed July 14, 2020)5 Lewis, Dyani, Mounting evidence suggests coronavirus is airborne — but health advice has not caught up, Nature, (accessed July 14, 2020)6Kowalski, (2013, June) Residential Application of the RxAir UV light Portable Air Purification Unit7 Kowalski, (2009, Dec. 1) Prediction of Virus Inactivation by the UV 4008 Kowalski, (2012, Jan20) Supplemental Air Purification for Hospitals and Health Care Facilities 9 Kowalski, Walsh, Petraitis (2020, March) 2020 COVID-19 Coronavirus Ultraviolet Susceptibility # # # About Vystar Corporation: Based in Worcester, Mass., Vystar® Corp. (OTCQB: VYST) is the majority owner of Rotmans Furniture and Carpet and environmentally friendly technologies and products to improve lives, such as RxAir® UV light air purification products, Vytex™ Natural Rubber Latex (NRL) and Fluid Energy Solutions. Vystar is the exclusive creator of Vytex, a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, "green" and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. For more information, visit About Bryan Stone, MD Dr. Bryan Stone combines his medical expertise as a board certified internal medicine and nephrology physician with a keen understanding of technology and an aptitude for invention to develop market-changing technologies. Dr. Stone is Desert Regional Medical Center's Chief of Medicine, Medical Director of Davita Cathedral City Dialysis Clinic, as well as Medical Application Specialist for Fluid Energy Conversion, a green energy division of Vystar with patented disruptive technologies. Forward-looking Statements: Investors are cautioned that certain statements contained in this document as well as some statements in periodic press releases and some oral statements of VYST officials are "Forward-Looking Statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act"). Forward-looking statements include statements which are predictive in nature, which depend upon or refer to future events or conditions, which include words such as "believes," "anticipates," "intends," "plans," "expects," and similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible future VYST actions, product development and delivery, which may be provided by management, are also forward-looking statements as defined by the Act. Forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements and to vary significantly from reporting period to reporting period. Although management believes that the assumptions made and expectations reflected in the forward-looking statements are reasonable, there is no assurance that the underlying assumptions will, in fact, prove to be correct or that actual future results will not be different from the expectations expressed in this report. These statements are not guarantees of future performance and VYST has no specific intention to update these statements.

Associated Press
30 minutes ago
- Associated Press
FDA vaccine chief leaving agency after less than 3 months
WASHINGTON (AP) — The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech companies, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad 'did not want to be a distraction' and was stepping down from his role as the FDA's top vaccine regulator 'to spend more time with his family,' a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. The people spoke on condition of anonymity to discuss internal personnel matters. Prasad joined the FDA in May after years as an academic researcher at the University of California San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks Prasad became a target of conservative activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchenne's muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker, Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term he signed the ' Right to Try ' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give dying patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued rejection letters this month to three small biotech firms seeking approval for new gene therapies. Prasad's predecessor in the role, Dr. Peter Marks, oversaw a steep rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA. which included overseeing the approval of the first COVID vaccines and therapies. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.